期刊文献+

“患者-家庭-社区”健康促进模式对社区原发性高血压患者的干预效果 被引量:2

Efficacy of patient-family-community health promotion model in intervening primary hypertensive patients in the community
下载PDF
导出
摘要 目的探讨"患者-家庭-社区"健康促进模式对社区原发性高血压患者的干预效果。方法 2014年1月到2016年12月期间,从文晖街道建有电子档案的原发性高血压患者随机选取320例,随机分为对照组(160例)与干预组(160例),对照组患者给予常规综合教育指导干预,干预组给予"患者-家庭-社区"健康促进模式干预。比较两组患者干预后临床有效率,干预前后血压变化情况及高血压相关知信行评分、患者服用药物依从性。结果对照组患者临床有效率为70.6%,干预组患者临床有效率为86.3%,二者比较有统计学差异(χ2=11.548,P<0.05)。干预后,两组患者收缩压和舒张压较干预前均下降,且干预组患者下降程度优于对照组,二者比较有统计学差异(P<0.05)。干预后,两组患者高血压相关知信行评分均上升,服药依从性均改善,且干预组优于对照组,差异有统计学意义(P<0.05)。结论 "患者-家庭-社区"健康促进模式能够提高高血压患者相关知信行和服用药物的依从性,有利于血压的控制,为今后开展社区高血压防治提供了参考。 Objective To evaluate the efficacy of patient-family-community health promotion model in intervening primary hypertensive patients in the community. Methods 320 patients with primary hypertension were randomly chosen as the subjects from those documented by Wenhui street community in the period from January 2014 to December 2016,and then divided into an experimental group( n = 160) and a control group( n = 160). The control group was given routine intervention whereas the experimental with patient-family-community health promotion. The clinical efficiency,the blood pressure,the hypertension related KAP score and the drug compliance of the two groups were compared. Results The clinical efficiency of the control group was 70. 6% whereas that of the experimental was 86. 3%. The difference was statistically significant( χ~2= 11.548,P0. 05). After the intervention,the systolic blood pressure and the diastolic blood pressure of both groups decreased; the degree of patients in the experimental group was better than that of the control group( P0. 05). After intervention,the hypertension related KAP score of both groups increased and the drug compliance of both groups became better; the degree of patients in the experimental group was better than that of the control group( P0. 05). Conclusions The patient-family-community health promotion model can improve hypertension related knowledge and drug compliance of primary hypertensive patients,facilitate the control of blood pressure,and provide reference for the prevention and treatment of hypertension in the community.
作者 孙小琳 王爱芬 SUN Xiao-lin;WANG Ai-ten(Wenhui Street Community Health Service Center of Xiacheng Hangzhou,Hangzhou 310004,China)
出处 《健康研究》 CAS 2018年第3期265-268,共4页 Health Research
关键词 健康促进 原发性高血压 社区 health promotion primalT hypertension eonnnunity
  • 相关文献

参考文献5

二级参考文献34

  • 1王继光.家庭血压监测中国专家共识[J].中国医学前沿杂志(电子版),2012,4(4):43-47. 被引量:27
  • 2孙萍,绳宇,张琳琳.干预对社区原发性高血压患者依从行为和自我功效影响的研究[J].医学与哲学(B),2007,28(7):30-32. 被引量:19
  • 3Bumier M. Medication adherence and persistence as the comerstone of ef- fective anti_hypertensive therapy[ J ]. Am J Hypertens, 2006,19( 11 ) : 1190- 1196.
  • 4Muntner P, Judd SE, Krousel-Wood M, et al. Low medication adher-ence and hypertension control among adults with CKD:data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study[ J ]. Am J Kidney Dis, 2010,56(3 ) : 447-457.
  • 5Munger MA, Van Tassell BW, LaFleur J. Medication nonadherence: an unr cardiovascular risk factor[ J ]. Med Gen Med, 2007,9 (3):58.
  • 6李姗.社区老年慢性病护理干预现状与进展[J].中国实用护理杂志,2013,29(2):27-28.
  • 7Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-report measure of medication adherence[J]. Med Care, 1986,24( 1 ) :67-74.
  • 8Morisky DE, Ang A, Krousel- Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting[J]. Clin Hy- pertens, 2008,1 O( 5 ) : 348 -354.
  • 9Cherry SB, Benner JS, Hussein MA, et al. The clinical and economic burden of nonadherence with antihypertensive and lipid- lowering therapy in hypertensive patients [ J ].Value Health, 2009,12 ( 4 ) : 489 - 497.
  • 10Law M,Wald N,Morris J. Lowering blood pressure to prevent myocardial infarction and stroke:a new preventive strategy [J ]. Health Technol Assess ,2003,7(31 ) : 1-94.

共引文献63

同被引文献16

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部